Search
for
Sort by
Research 211–240 of 1000+
- Effective holistic characterization of small molecule effects using heterogeneous biological networks
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Stereotactic Body Radiation Therapy As a Derivative of Stereotactic Radiosurgery: Clinically Independent But With Enduring Common Themes
- Antiproliferative and antioxidant potential of Tridax procumbens extracts against various human cancer cell lines: An insight for medicines from weeds
- Transcriptome analysis to identify the downstream genes of androgen receptor in dermal papilla cells
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Bicalutamide: A review
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- Alternative androgen pathways
- PD23-01 INHIBITOR OF 5A-REDUCTASE TYPES II PROMOTES THE INFILTRATION OF CD8+T CELLS IN BPH TISSUES.
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Moving Chemoprevention Forward into the Most Promising Areas of Study
- Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5α-reductase inhibitors
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- β‐Sitosterol—Dietary sources and role in cancer and diabetes management
- Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Saw palmetto and finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Effects of 5-alpha reductase inhibitors
- QSAR Analysis of a Series of Hydantoin‐based Androgen Receptor Modulators and Corresponding Binding Affinities